You might want to add the FDA's "answer" to Teva's t-Lovenox application which is due by the end of January or possibly you have totally discounted anything that Marth says.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.